Results 81 to 90 of about 32,822 (166)

The effect of dual antiplatelet therapy in different patterns of watershed infarction: Subgroup analysis of the INSPIRES trial. [PDF]

Cell Rep Med
Liu C, Li Y, Liu Z, Gao Y, Zhang Q, Wabnitz AM, Pan Y, Yan H, Chen W, Johnston SC, Wang D, Amarenco P, Bath PM, Wang Y, Wang Y, Guan L.   +15 more
europepmc   +1 more source

Prophylactic tirofiban versus oral dual antiplatelet therapy in patients undergoing endovascular treatment of intracranial aneurysms: A meta-analysis. [PDF]

Medicine (Baltimore)
Miao Y, Li Q, Chen J, Liu Z.
europepmc   +1 more source

Tirofiban with sequential dual antiplatelet therapy in mild acute ischemic stroke (TiMIS): protocol for a multicenter, randomized controlled trial. [PDF]

Ann Med
Xu J, Peng H, Zhu Y, Xu F, Zhu L, Yang J, Kang T, Wang S, Yu X, Liu J, Wang P, Zhang M, Liu CF, Cao Y, Shi J.   +14 more
europepmc   +1 more source

Associations of new intracranial haemorrhage, ischaemic stroke and survival with dual antiplatelet therapy regimen or duration after endovascular treatment for ruptured cerebral aneurysm. [PDF]

Stroke Vasc Neurol
Perng PS, Chang Y, Chuang MT, Wong CE, Sun YT, Wang HK, Lee JS, Wang LC, Huang CY.   +8 more
europepmc   +1 more source

Lp-PLA2 Activity and Genotype-Guided Dual Antiplatelet Therapy in Minor Stroke or Transient Ischemic Attack. [PDF]

Stroke
Lin J, Zhou H, Wang Y, Jin A, Li S, Zhang L, Meng X, Xie X, Jing J, Jiang Y, Wang Y, Zhao X, Li H, Li Z, Wang Y, CHANCE-2 Investigators.   +15 more
europepmc   +1 more source

Antiplatelet dilemma: Clopidogrel or aspirin for long-term cardiovascular protection after dual antiplatelet therapy following PCI. [PDF]

Medicine (Baltimore)
Moawad MHED, Elsayed M, Serag I, Wagih RM, Elgharabawi A, Ahmed Y, Elkholy A, Abdelraouf A, Alsolami AM, Alattar A, Alkhawaldeh IM, Abdul-Hafez HA, Gadelmawla AF, Abouzid M, Mohamed MO, Bisht O, Elkholy M.   +16 more
europepmc   +1 more source

Efficacy and Safety of Dual Antiplatelet Therapy in Acute Ischemic Stroke With Recurrent Symptoms Post-thrombolysis: A Retrospective Cohort Study From the TriNetX US Collaborative Network. [PDF]

Cureus
Nwogu C, Stupin J, Neutel D, Thomas SM, Tablieh L, Wu Y, Yelverton N, Kodankandath TV.   +7 more
europepmc   +1 more source

Extending Dual Antiplatelet Therapy Beyond 3 Months in Acute Ischemic Stroke Due to Large-Artery Atherosclerosis. [PDF]

J Am Heart Assoc
Lee M, Oh MS, Yu KH, Lee BC, Kim BJ, Kim JY, Kang J, Kim DY, Park JM, Kang K, Park TH, Lee JY, Lee KB, Hong KS, Park HK, Cho YJ, Eog-Kim D, Lee SJ, Kim JG, Lee J, Cha JK, Kim DH, Kim JT, Choi KH, Choi JC, Sohn SI, Hong JH, Lee SH, Kim C, Shin DI, Yum KS, Lee J, Lee JS, Gorelick PB, Bae HJ, CRCS‐K Investigators *.   +35 more
europepmc   +1 more source

Preclinical Efficacy of a Hemostatic Agent in Overcoming Dual Antiplatelet Therapy. [PDF]

JACC Basic Transl Sci
Efimenko E, Zhao H, Moskowitz K, Smith C, Pyo R, Diacovo TG.   +5 more
europepmc   +1 more source

Prior Dual Antiplatelet Therapy and Mortality After Intracerebral Hemorrhage: A Danish Nationwide Cohort Study. [PDF]

J Am Heart Assoc
Ovesen C, García Rodríguez LA, Hallas J, Storm C, Hald SM, Möller S, Selim M, Gaist D.   +7 more
europepmc   +1 more source